Tanguler Tolga Insider Trades

Insider Trading History

Track insider trading activity for Tanguler Tolga. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Lexeo Therapeutics
Lexeo Therapeutics LXEO
Director
Holding Value $162k 35,000 shares
Last Trade
Jun 25, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$165k 35,000 shares
$4.70
$4.62
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Commercial Officer
Holding Value $10.3M 36,500 shares
Last Trade
Mar 04, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$746k 2,309 shares
$323.09
$281.26
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Commercial Officer
Holding Value $10.7M 38,204 shares
Last Trade
Mar 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.96M 15,249 shares
$325.07
$281.26
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Commercial Officer
Holding Value $10.7M 38,157 shares
Last Trade
Mar 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$524k 1,598 shares
$327.65
$281.26
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Commercial Officer
Holding Value $9.4M 33,435 shares
Last Trade
Feb 27, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$554k 1,666 shares
$332.76
$281.26
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Feb 27, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$554k 1,666 shares
$332.76
$281.26
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Commercial Officer
Holding Value $8.94M 31,769 shares
Last Trade
Feb 13, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$607k 1,959 shares
$310.08
$281.26
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Commercial Officer
Holding Value $9.49M 33,728 shares
Last Trade
Feb 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.23M 4,000 shares
$308.48
$281.26
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Commercial Officer
Holding Value $8.78M 31,199 shares
Last Trade
Jan 12, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$548k 1,510 shares
$362.86
$281.26
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Commercial Officer
Holding Value $8.79M 31,238 shares
Last Trade
Jan 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.51M 3,800 shares
$398.29
$281.26
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Commercial Officer
Holding Value $8.1M 28,788 shares
Last Trade
Oct 02, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$635k 1,405 shares
$452.05
$281.26
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Commercial Officer
Holding Value $8.11M 28,843 shares
Last Trade
Oct 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.31M 2,851 shares
$460.65
$281.26
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Commercial Officer
Holding Value $8.23M 29,271 shares
Last Trade
Aug 29, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.56M 3,474 shares
$448.37
$281.26
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Commercial Officer
Holding Value $8.67M 30,823 shares
Last Trade
Aug 18, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$633k 1,396 shares
$453.27
$281.26
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Commercial Officer
Holding Value $8.68M 30,862 shares
Last Trade
Aug 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.28M 2,851 shares
$448.91
$281.26
Lexeo Therapeutics
Lexeo Therapeutics LXEO
Director
Holding Value $67.4k 14,583 shares
Last Trade
Jun 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$61k 14,583 shares
$4.18
$4.62
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Commercial Officer
Holding Value $7.97M 28,351 shares
Last Trade
Mar 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$115k 471 shares
$243.78
$281.26
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Commercial Officer
Holding Value $8.01M 28,482 shares
Last Trade
Mar 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.9M 7,819 shares
$243.53
$281.26
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Commercial Officer
Holding Value $4.17M 14,830 shares
Last Trade
Feb 28, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$124k 513 shares
$241.68
$281.26
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Commercial Officer
Holding Value $4.18M 14,858 shares
Last Trade
Feb 27, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$395k 1,667 shares
$237.10
$281.26

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up